VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CRBU
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CRBUCaribou Biosciences, Inc.
$1.22$121M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRBUQuarterly Financials

Caribou Biosciences, Inc. (CRBU) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Caribou Biosciences, Inc. (CRBU) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

CRBU Income Statement

Quarterly statement

CRBU Income Statement

Caribou Biosciences, Inc. (CRBU) annual income statement — 7-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue1.5M2.4M3.94M2.2M2.67M2.35M2.08M2.02M3.46M2.43M3.56M23.66M3.75M3.5M3.69M3.3M4.19M2.66M2.56M3.98M
Revenue Growth %-43.79%1.87%89.74%8.6%-23.01%-3.13%-41.62%-91.45%-7.75%-30.64%-3.63%616.38%-10.42%31.46%44.28%-16.95%184.01%67.97%160.06%-
Cost of Goods Sold0649K022.4M1.3M1.74M29.86M29.82M856K710K1.97M28.58M26.5M25.71M25.74M022.58M13.92M273K15.83M
COGS % of Revenue-27.08%-1019.15%48.67%74.08%1437.84%1473.37%24.71%29.23%55.48%120.8%705.81%734.12%697.07%-538.62%522.67%10.67%398.11%
Gross Profit1.5M1.75M3.94M-20.2M1.37M610K-27.79M-27.8M2.61M1.72M1.58M-4.92M-22.75M-22.21M-22.04M3.3M-18.39M-11.26M2.29M-11.86M
Gross Margin %100%72.92%100%-919.15%51.33%25.92%-1337.84%-1373.37%75.29%70.77%44.52%-20.8%-605.81%-634.12%-597.07%100%-438.62%-422.67%89.33%-298.11%
Gross Profit Growth %9.5%186.56%114.18%27.32%-47.51%-64.51%-1854.23%-464.75%111.46%107.74%107.19%-249.02%-23.72%-97.22%-1064.3%127.86%-1345.73%-31.25%120.71%-
Operating Expenses26.84M28.03M32.39M9.2M48.95M43.52M11.09M10.44M46.11M47.72M39.03M9.71M10.12M8.91M8.53M29.84M10.04M9.59M22.69M6.76M
OpEx % of Revenue1790.39%1169.3%821.97%418.43%1835.28%1849.68%533.85%515.86%1331.09%1964.64%1096.85%41.04%269.51%254.4%231.15%903.42%239.6%360.1%886.71%169.98%
Selling, General & Admin7.9M8.07M8.58M9.2M10.4M9.73M10.49M5.94M10.63M14.64M7.75M9.71M10.12M8.91M8.53M9.85M10.04M9.59M7.58M6.76M
SG&A % of Revenue526.75%336.5%217.69%418.43%390.06%413.73%504.96%293.53%306.84%602.84%217.73%41.04%269.51%254.4%231.15%298.18%239.6%360.1%296.21%169.98%
Research & Development18.94M20.61M23.82M22.4M27.69M35.53M30.46M30.42M35.48M33.79M31.28M28.58M26.5M25.71M26.34M19.99M22.58M13.92M15.11M15.83M
R&D % of Revenue1263.64%859.87%604.29%1019.15%1038.32%1510.03%1466.73%1503.01%1024.25%1391.03%879.12%120.8%705.81%734.12%713.33%605.24%538.62%522.67%590.5%398.11%
Other Operating Expenses0-649K0-1000K1000K-1000K-1000K-1000K0-710K0-1000K-1000K-1000K-1000K0-1000K-1000K0-1000K
Operating Income-25.34M-26.28M-28.45M-29.4M-47.58M-42.91M-38.88M-38.24M-43.5M-46M-37.44M-14.63M-32.87M-31.12M-30.58M-26.54M-28.43M-20.85M-20.41M-18.62M
Operating Margin %-1690.39%-1096.37%-721.97%-1337.58%-1783.95%-1823.76%-1871.69%-1889.23%-1255.8%-1893.87%-1052.33%-61.84%-875.31%-888.52%-828.22%-803.42%-678.22%-782.77%-797.38%-468.09%
Operating Income Growth %46.74%38.76%26.81%23.11%-9.37%6.71%-3.83%-161.31%-32.35%-47.84%-22.45%44.86%-15.61%-49.22%-49.86%-42.55%-78.09%-58.28%-34.13%-
EBITDA-26.4M-25.63M-27.77M-28.77M-46.41M-41.75M-37.69M-37.06M-42.65M-45.29M-36.7M-13.05M-32.25M-30.53M-30.07M-26.09M-28.07M-20.55M-20.13M-18.36M
EBITDA Margin %-1760.91%-1069.3%-704.67%-1308.87%-1740.19%-1774.25%-1814.68%-1831.08%-1231.09%-1864.64%-1031.53%-55.17%-858.88%-871.7%-814.52%-789.8%-669.68%-771.21%-786.71%-461.55%
EBITDA Growth %43.13%38.61%26.32%22.37%-8.83%7.82%-2.69%-183.91%-32.23%-48.37%-22.05%49.96%-14.88%-48.59%-49.37%-42.12%-78.42%-58.6%-34.28%-
D&A (Non-Cash Add-back)0649K682K631K1.17M1.17M1.18M1.18M856K710K740K1.58M617K589K506K450K358K308K273K260K
EBIT-26.4M-25.09M-27.04M-27.55M-35.43M-39.99M-38.27M-34.68M-37.7M-41.23M-34.31M-14.63M-32.87M-31.12M-30.58M-26.54M-28.43M-20.85M-18.16M-18.62M
Net Interest Income000000000004.77M00000251K76K22K
Interest Income000000000004.77M00000251K76K22K
Interest Expense00000000000000000000
Other Income/Expense1.06M1.2M1.42M1.85M-6.52M2.92M3.38M3.55M5.8M4.77M3.13M4.63M3.35M3.07M3.66M-110K1.73M1.76M2.25M-2.36M
Pretax Income-24.28M-25.09M-27.04M-27.55M-54.1M-39.99M-35.5M-34.68M-37.7M-41.23M-34.31M-10M-29.52M-28.04M-26.92M-26.65M-26.7M-19.09M-18.16M-20.97M
Pretax Margin %-1619.88%-1046.52%-686.07%-1253.32%-2028.42%-1699.58%-1709.15%-1713.64%-1088.25%-1697.57%-964.36%-42.27%-786.13%-800.8%-729.12%-806.75%-636.86%-716.52%-709.57%-527.38%
Income Tax00-550K000-9K000193K00070K000321K0
Effective Tax Rate %0%0%2.03%0%0%0%0.03%0%0%0%-0.56%0%0%0%-0.26%0%0%0%-1.77%0%
Net Income-24.28M-25.09M-26.49M-27.55M-54.1M-39.99M-35.49M-34.68M-37.7M-41.23M-34.51M-10M-29.52M-28.04M-26.99M-26.65M-26.7M-19.09M-18.48M-20.97M
Net Margin %-1619.88%-1046.52%-672.11%-1253.32%-2028.42%-1699.58%-1708.71%-1713.64%-1088.25%-1697.57%-969.79%-42.27%-786.13%-800.8%-731.01%-806.75%-636.86%-716.52%-722.12%-527.38%
Net Income Growth %55.11%37.27%25.36%20.57%-43.51%3.01%-2.85%-246.77%-27.7%-47.03%-27.85%62.46%-10.57%-46.92%-46.05%-27.05%-86.55%-45.06%-25.68%-
Net Income (Continuing)-24.28M-25.09M-26.49M-27.55M-54.1M-39.99M-35.49M-34.68M-37.7M-41.23M-34.51M-10M-29.52M-28.04M-26.99M-26.65M-26.7M-19.09M-18.48M-20.97M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.24-0.26-0.28-0.30-0.58-0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.46-0.44-0.44-0.44-0.32-0.31-0.46
EPS Growth %58.62%39.53%28.21%21.05%-38.1%6.52%0%-216.67%12.5%0%11.36%72.73%-9.09%-43.75%-41.94%4.35%-69.23%33.33%41.51%-
EPS (Basic)-0.24-0.26-0.28-0.30-0.58-0.43-0.39-0.38-0.42-0.46-0.39-0.12-0.48-0.46-0.44-0.44-0.44-0.32-0.31-0.46
Diluted Shares Outstanding100.99M95.86M94.54M93.29M93.03M92.68M90.32M90.46M90.34M89.3M88.43M83.78M61.42M61.19M61M60.89M60.76M60.55M60.18M45.89M
Basic Shares Outstanding100.99M95.86M94.54M93.29M93.03M92.68M90.32M90.46M90.34M89.3M88.43M83.78M61.42M61.19M61M60.89M60.76M60.55M60.18M45.89M
Dividend Payout Ratio--------------------